《新股表现》康基医疗(09997.HK)高开86.6%报25.9元
康基医疗(09997.HK)暗盘高开73%报24元,最高见26.3元,收26.05元高上市价87.7%;该股首挂开报25.9元,较上市价13.88元,高86.6%,市前成交3,368万股。
康基医疗是内地最大微创外科手术器械及配件(MISIA)平台。是次来港上市共发售近2.254亿股,并已引入包括富达投资及贝莱德等7名基石投资者,合共认购9,213.15万股;其中10%公开发售获逾988倍超购,已启动回拨机制占比增至50%,认购一手中签率仅9%,股份以招股范围(12.36-13.88元)上限定价,料集资净额约29.56亿元,主要用作提升产能和加强制造能力、投资销售与营销活动、以及为研发活动、潜在战略投资和收购提供资金等。上市联席保荐人分别为高盛、中信证券及美银证券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.